8-K ·Filed Apr 7, 2026
8-K material event: Items 4.01
Actionable Insight • Neutral
Monitor for future audit-related disclosures or delays in filings, which could signal underlying issues; otherwise, this is a routine auditor rotation with no red flags.
Final — all horizons settled through T+60d
EDIT ▲ +32.25% at T+60d
NEUTRAL call +32.25% · α vs SPY +21.79% · entry $2.76 → $3.65
T+1d
+4.71%
call +4.71% · α +4.14%
$2.89
settled 7mo ago
T+5d
+22.10%
call +22.10% · α +18.58%
$3.37
settled 7mo ago
T+20d
+10.14%
call +10.14% · α +1.60%
$3.04
settled 6mo ago
T+60d
+32.25%
call +32.25% · α +21.79%
$3.65
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Editas Medicine dismissed Ernst & Young as its auditor and appointed PricewaterhouseCoopers (PwC) effective April 1, 2026, following a formal review. The prior auditor confirmed no disagreements or reportable events existed.
Key Facts
- Ernst & Young was dismissed as independent auditor; PwC was appointed as successor.
- No disagreements or reportable events were identified between the company and Ernst & Young.
- The change follows a formal review process initiated by the Audit Committee.
- Ernst & Young confirmed agreement with the disclosure in its letter to the SEC.
Financial Impact
No immediate financial impact disclosed; audit fee changes possible but not quantified.
audit feesaccounting oversight
Risk Factors
- Perception of auditor change without clear justification may raise investor concern.
- PwC onboarding could lead to minor delays in future financial reporting.
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001650664-26-000030 |
| Exhibit: ex161lettertosec.htm | 0001650664-26-000030 |
| Document: 0001650664-26-000030-index-headers.html | 0001650664-26-000030 |
| Document: 0001650664-26-000030-index.html | 0001650664-26-000030 |
| Document: 0001650664-26-000030.txt | 0001650664-26-000030 |
16 reports for EDIT
60% Hit rate @ T+20 Went positive at some point 9 of 11 best @ T+20▲ +23.25%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 8-K | $2.84 | awaiting T+20 | — | $2.40 (−15.49%) |
Sep 9, 2026 6w ago | EFFECT | $2.77 $2.75 | ▼ −0.72% | ▼ −2.92% | $2.40 (−13.36%) |
Jun 11, 2026 19w ago | Institutional Cluster | $2.44 $3.30 | ▲ +35.25% | ▲ +33.35% | $2.40 (−1.64%) |
May 26, 2026 21w ago | 424B5 | $3.57 $2.74 | ▲ +23.25% | ▲ +21.35% | $2.40 (+32.77%) |
May 26, 2026 21w ago | 8-K | $3.57 $2.74 | ▲ +23.25% | ▲ +21.35% | $2.40 (+32.77%) |
May 26, 2026 21w ago | Press Release | $3.08 $2.83 | ▲ +8.12% | ▲ +6.17% | $2.40 (+22.08%) |
May 26, 2026 21w ago | 8-K | $3.08 $2.83 | ▼ −8.12% | ▼ −6.17% | $2.40 (−22.08%) |
May 26, 2026 21w ago | 424B5 | $3.08 $2.83 | ▲ +8.12% | ▲ +6.17% | $2.40 (+22.08%) |
May 26, 2026 21w ago | Press Release | $3.08 $2.83 | ▲ +8.12% | ▲ +6.17% | $2.40 (+22.08%) |
May 26, 2026 21w ago | Press Release | $3.08 $2.83 | ▼ −8.12% | ▼ −6.17% | $2.40 (−22.08%) |
Showing 10 of 16
US Market Status
Market Closed — Opens Tue (15h 55m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers